Infliximab-abda Intravenous and Recombinate recombinant
Determining the interaction of Infliximab-abda Intravenous and Recombinate recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: infliximab
Brand name: Inflectra, Remicade, Renflexis
Synonyms: Infliximab, InFLIXimab
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant), Recombinate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Infliximab-abda Intravenous-Recombivax
- Infliximab-abda Intravenous-Recombivax HB
- Infliximab-abda Intravenous-Recombivax HB Adult
- Infliximab-abda Intravenous-Recombivax HB Dialysis Formulation
- Infliximab-abda Intravenous-Recombivax HB Pediatric/Adolescent
- Infliximab-abda Intravenous-Recort Plus
- Recombinate recombinant-Infliximab-dyyb
- Recombinate recombinant-Infliximab-dyyb Intravenous
- Recombinate recombinant-Infliximab-qbtx Intravenous
- Recombinate recombinant-Influenza A (H1N1) 2009 Monovalent Vaccine
- Recombinate recombinant-Influenza A H1N1 Intranasal
- Recombinate recombinant-Influenza A Vaccine